Monotherapy trials with the new antiepileptic drugs: study designs, practical relevance and ethical implications (Q33545649)

27 July 2017

1 reference

title

Monotherapy trials with the new antiepileptic drugs: study designs, practical relevance and ethical implications (English)

1 reference

27 July 2017

0 references

Perucca E

1

1 reference

27 July 2017

Tomson T

series ordinal

2

1 reference

27 July 2017

publication date

1 February 1999

1 reference

27 July 2017

1 reference

27 July 2017

volume

33

1 reference

27 July 2017

issue

2-3

1 reference

27 July 2017

page(s)

247-262

1 reference

Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Monotherapy antiepileptic drug trials in patients undergoing presurgical assessment: methodological problems and possibilities

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

The management of epilepsy in the 1990s. Acquisitions, uncertainties and priorities for future research

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Gabapentin monotherapy: I. An 8-day, double-blind, dose-controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 88/89

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Monotherapy trials of new antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 82/83

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Felbamate: a double-blind controlled trial in patients undergoing presurgical evaluation of partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Double-blind substitution of vigabatrin and valproate in carbamazepine-resistant partial epilepsy. 012 Study group.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Monotherapy clinical trials of new antiepileptic drugs: design, indications, and controversies

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

The cost of epilepsy in the United Kingdom: an estimation based on the results of two population-based studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Efficacy of felbamate monotherapy in patients undergoing presurgical evaluation of partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Felbamate monotherapy for partial-onset seizures: an active-control trial

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Innovative designs of controlled clinical trials in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Hazards of inference: the active control investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

The new generation of antiepileptic drugs: advantages and disadvantages

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Evaluation of drug treatment outcome in epilepsy: a clinical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Innovative monotherapy trial designs for the assessment of antiepileptic drugs: a critical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Clinical trials of investigational antiepileptic drugs: monotherapy designs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Comparison of oxcarbazepine and carbamazepine: a double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

The continuing unethical use of placebo controls

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Felbamate monotherapy: controlled trial in patients with partial onset seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Topiramate monotherapy for partial onset seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Tiagabine monotherapy in the treatment of partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Vigabatrin vs. carbamazepine monotherapy in newly diagnosed focal epilepsy: a randomized response conditional cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Gabapentin in naive childhood absence epilepsy: results from two double-blind, placebo-controlled, multicenter studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. The Paediatric EPITEG Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

Difficulties in extrapolating from clinical trial data to clinical practice: the case of antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900095-3

7 January 2021

10.1016/S0920-1211(98)00095-3

Identifiers

DOI

1 reference

27 July 2017

1 reference